Sign up to watch this video
Free access to all Sound Bites content
Dr. Eric Singhi reviews 5-year efficacy of cemiplimab + chemotherapy in aNSCLC (Video 1/3)
Published Jan 22, 2026
Medical Professional
EMPOWER Squamous
Related Videos
Dr. Joshua Richter reviews the safety profile and AE management of MeziKd (Video 2/3)
Joshua Richter, MD
Dr. Joe Mendez reviews the adjuvant vorasidenib patient profile in low-grade gliomas (Video 2/3)
Joe Mendez, MD
Dr. Sandip Patel discusses the impact of adding chemotherapy in patients progressing on 1L osimertinib. (Video 1/3)
Sandip Patel, MD
Dr. Laura van ‘t Veer reviews ctDNA clearance at week 3 as an early indicator in breast cancer (Video 2/3)
Laura van 't Veer, PhD
Dr. Joshua Richter discusses the MOA of CELMoDs and efficacy of MeziKd (Video 1/3)
Joshua Richter, MD
Dr. Joe Mendez reviews vorasidenib for IDH mutant low-grade gliomas (Video 1/3)
Joe Mendez, MD
IDEOlogy Health Ranks No. 772 on the 2025 Inc. 5000 Fastest-Growing Private Companies in America
© 2026 IDEOlogy Health. All product names, logos, brands, trademarks and registered trademarks are property of their respective owners and their use(s) do not necessarily imply endorsement.